Cargando…

Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5)

OBJECTIVE: To compare the efficacy and safety of two doses of once-weekly dulaglutide, a glucagon-like peptide 1 receptor agonist, to sitagliptin in uncontrolled, metformin-treated patients with type 2 diabetes. The primary objective was to compare (for noninferiority and then superiority) dulagluti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nauck, Michael, Weinstock, Ruth S., Umpierrez, Guillermo E., Guerci, Bruno, Skrivanek, Zachary, Milicevic, Zvonko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2014
Materias:	Clinical Care/Education/Nutrition/Psychosocial Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113177/ https://www.ncbi.nlm.nih.gov/pubmed/24742660 http://dx.doi.org/10.2337/dc13-2761

Ejemplares similares

Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5). Diabetes Care 2014;37:2149–2158
por: Nauck, Michael, et al.
Publicado: (2015)

Safety and efficacy of once‐weekly dulaglutide versus sitagliptin after 2 years in metformin‐treated patients with type 2 diabetes (AWARD‐5): a randomized, phase III study
por: Weinstock, R. S., et al.
Publicado: (2015)

Pancreatic Safety of Sitagliptin in the TECOS Study
por: Buse, John B., et al.
Publicado: (2017)

Effect of Exenatide, Sitagliptin, or Glimepiride on β-Cell Secretory Capacity in Early Type 2 Diabetes
por: Gudipaty, Lalitha, et al.
Publicado: (2014)

Effects of Prandial Versus Fasting Glycemia on Cardiovascular Outcomes in Type 2 Diabetes: The HEART2D trial
por: Raz, Itamar, et al.
Publicado: (2009)

HbA(1c) Reduction in Dulaglutide-Treated Patients Irrespective of Duration of Diabetes, Microvascular Disease, and BMI: A Post Hoc Analysis From the REWIND Trial
por: Kwan, Anita Y.M., et al.
Publicado: (2022)

Sitagliptin versus mitiglinide switched from mealtime dosing of a rapid-acting insulin analog in patients with type 2 diabetes: a randomized, parallel-group study
por: Takeshita, Yumie, et al.
Publicado: (2015)

Pleiotropic effects of sitagliptin versus voglibose in patients with type 2 diabetes inadequately controlled via diet and/or a single oral antihyperglycemic agent: a multicenter, randomized trial
por: Matsushima, Yukiko, et al.
Publicado: (2016)

Randomized Controlled Trial of Insulin Supplementation for Correction of Bedtime Hyperglycemia in Hospitalized Patients With Type 2 Diabetes
por: Vellanki, Priyathama, et al.
Publicado: (2015)

A randomized controlled trial comparing treatment with oral agents and basal insulin in elderly patients with type 2 diabetes in long-term care facilities
por: Pasquel, Francisco J, et al.
Publicado: (2015)

Achieving the composite endpoint of glycated haemoglobin <7.0%, no weight gain and no hypoglycaemia in the once‐weekly dulaglutide AWARD programme
por: Dungan, K. M., et al.
Publicado: (2016)

Clinical Decision Support for Glycemic Management Reduces Hospital Length of Stay
por: Pichardo-Lowden, Ariana R., et al.
Publicado: (2022)

Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCO-CABG Trial
por: Umpierrez, Guillermo, et al.
Publicado: (2015)

Effect of once‐weekly dulaglutide versus insulin glargine in people with type 2 diabetes and different baseline glycaemic patterns: A post hoc analysis of the AWARD‐2 clinical trial
por: Giorgino, Francesco, et al.
Publicado: (2019)

Dapagliflozin’s Effects on Glycemia and Cardiovascular Risk Factors in High-Risk Patients With Type 2 Diabetes: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With a 28-Week Extension
por: Cefalu, William T., et al.
Publicado: (2015)

Recommendations for management of diabetes during Ramadan: update 2015
por: Ibrahim, Mahmoud, et al.
Publicado: (2015)

Linagliptin monotherapy compared with voglibose monotherapy in patients with type 2 diabetes undergoing hemodialysis: a 12-week randomized trial
por: Mori, Katsuhito, et al.
Publicado: (2016)

Therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin, and lobeglitazone in drug-naïve patients with type 2 diabetes: initial triple study
por: Lim, Soo, et al.
Publicado: (2020)

Integrative health coaching: a behavior skills approach that improves HbA1c and pharmacy claims-derived medication adherence
por: Wolever, Ruth Q, et al.
Publicado: (2016)

Long-term changes in carbohydrate tolerance, insulin secretion and action in African-American patients with obesity and history of hyperglycemic crises
por: Vellanki, Priyathama, et al.
Publicado: (2020)

Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)
por: Frias, Juan P., et al.
Publicado: (2021)

Clinical characteristics and outcomes of patients with end-stage renal disease hospitalized with diabetes ketoacidosis
por: Galindo, Rodolfo J, et al.
Publicado: (2020)

Beneficial Effects of Insulin on Glycemic Control and β-Cell Function in Newly Diagnosed Type 2 Diabetes With Severe Hyperglycemia After Short-Term Intensive Insulin Therapy
por: Chen, Harn-Shen, et al.
Publicado: (2008)

Impact of Diabetes and Its Treatment on Cognitive Function Among Adolescents Who Participated in the Diabetes Control and Complications Trial
por: Musen, Gail, et al.
Publicado: (2008)

Ser1369Ala Variant in Sulfonylurea Receptor Gene ABCC8 Is Associated With Antidiabetic Efficacy of Gliclazide in Chinese Type 2 Diabetic Patients
por: Feng, Yan, et al.
Publicado: (2008)

A1C but Not Serum Glycated Albumin Is Elevated in Late Pregnancy Owing to Iron Deficiency
por: Hashimoto, Kunihiko, et al.
Publicado: (2008)

Reduced Progression to Type 2 Diabetes From Impaired Glucose Tolerance After a 2-Day In-Hospital Diabetes Educational Program: The Joetsu Diabetes Prevention Trial
por: Kawahara, Tetsuya, et al.
Publicado: (2008)

Weight Change in Diabetes and Glycemic and Blood Pressure Control
por: Feldstein, Adrianne C., et al.
Publicado: (2008)

Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of β-Cell Function in Therapeutic Trials in Type 1 Diabetes
por: Greenbaum, Carla J., et al.
Publicado: (2008)

Antecedent Hyperglycemia Is Associated With an Increased Risk of Neutropenic Infections During Bone Marrow Transplantation
por: Derr, Rachel L., et al.
Publicado: (2008)

Prediction of the Onset of Disturbed Eating Behavior in Adolescent Girls With Type 1 Diabetes
por: Olmsted, Marion P., et al.
Publicado: (2008)

Superior Mesenteric Artery Syndrome in Type 1 Diabetes Masquerading as Gastroparesis
por: Meneghini, Luigi F., et al.
Publicado: (2008)

Can Admission and Fasting Glucose Reliably Identify Undiagnosed Diabetes in Patients With Acute Coronary Syndrome?
por: Okosieme, Onyebuchi E., et al.
Publicado: (2008)

Is a Priming Dose of Insulin Necessary in a Low-Dose Insulin Protocol for the Treatment of Diabetic Ketoacidosis?
por: Kitabchi, Abbas E., et al.
Publicado: (2008)

Metformin, Sulfonylureas, or Other Antidiabetes Drugs and the Risk of Lactic Acidosis or Hypoglycemia: A nested case-control analysis
por: Bodmer, Michael, et al.
Publicado: (2008)

Effect of Vitamin K Supplementation on Insulin Resistance in Older Men and Women
por: Yoshida, Makiko, et al.
Publicado: (2008)

Sprint Training Increases Muscle Oxidative Metabolism During High-Intensity Exercise in Patients With Type 1 Diabetes
por: Harmer, Alison R., et al.
Publicado: (2008)

Predictors of Cognitive Decline in Older Individuals With Diabetes
por: Bruce, David G., et al.
Publicado: (2008)

Barriers to Physical Activity Among Patients With Type 1 Diabetes
por: Brazeau, Anne-Sophie, et al.
Publicado: (2008)

Duration of Nocturnal Hypoglycemia Before Seizures
por: Buckingham, Bruce, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_8t7qogm5racsb6uv10t7a4poer